Novateor Research Laboratories Stock Screener | Share Price & Fundamental Analysis
NOVATEOR
Personal Care
Screen Novateor Research Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹14.50 Cr.
P/B Ratio
1.31
EPS (TTM)
₹0.17
Dividend Yield
-
Debt to Equity
0.11
52W High
-
52W Low
-
Operating Margin
-39.00%
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹13.00
Total Equity
₹11.00
Novateor Research Laboratories Share Price History - Stock Screener Chart
Screen NOVATEOR historical share price movements with interactive charts. Analyze price trends and patterns.
Novateor Research Laboratories Company Profile - Fundamental Screener
Screen Novateor Research Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NOVATEOR shares.
Sector
Consumer Goods
Industry
Personal Care
Sub-Sector
Personal Care
Segment
E
ISIN
INE08JY01013
Novateor Research Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen NOVATEOR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 13 | 11 | 9 | 8 | 9 | 9 | 4 | 2 | 2 | 2 |
| Current Assets | 9 | 8 | 7 | 6 | 6 | 5 | 1 | 0 | 0 | 0 |
| Fixed Assets | 3 | 2 | 2 | 2 | 3 | 4 | 4 | 2 | 2 | 2 |
| Liabilities | ||||||||||
| Total Liabilities | 13 | 11 | 9 | 8 | 9 | 9 | 4 | 2 | 2 | 2 |
| Current Liabilities | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 11 | 9 | 8 | 8 | 9 | 9 | 4 | 1 | 1 | 1 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 0 | 0 | 0 |
| Reserves & Surplus | 3 | 4 | 3 | 3 | 4 | 4 | 1 | 1 | 1 | 1 |
Novateor Research Laboratories Income Statement Screener - Profit & Revenue Analysis
Intrinsic ValueScreen NOVATEOR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 3 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -39.00% | -5.00% | -27.00% | -28.00% | -25.00% | -176.00% | -35.00% | 71.00% | 59.00% | 42.00% | -6.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.00 | 0.17 | 0.06 | 0.08 | -0.47 | 0.02 | -0.02 | 0.74 | 0.18 | -0.62 | 0.05 | 0.30 |
Novateor Research Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen NOVATEOR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | -1 | -1 | 0 | -3 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 1 | 0 | 0 | -2 | 0 | 0 | 0 |
| Financing Activities | 1 | 1 | 1 | 0 | 0 | 4 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Screen NOVATEOR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept | 2023-Mar | 2022-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.90% | 51.60% | 60.87% | 60.87% | 60.87% | 60.87% | 60.87% | 60.87% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.90% | 29.11% | 26.52% | 27.14% | 26.89% | 26.52% | 25.77% | 30.86% |
| Other Holding | 19.19% | 19.29% | 12.61% | 11.99% | 12.24% | 12.61% | 13.36% | 8.27% |
| Shareholder Count | 172 | 164 | 160 | 122 | 118 | 113 | 118 | 138 |
Novateor Research Laboratories Dividend Screener - Share Yield Analysis
Screen NOVATEOR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Novateor Research Laboratories Index Membership - Market Screener Classification
Screen NOVATEOR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Novateor Research Laboratories Market Events Screener - Corporate Actions
Screen NOVATEOR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.82% | ||
| Annual General Meeting | NA | -22.17% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.01% |
| 2024-07-20 | 2024-07-20 | Extraordinary General Meeting | NA | 8.57% |
| 2023-12-03 | 2023-12-03 | Extraordinary General Meeting | NA | -11.67% |
Novateor Research Laboratories Competitors Screener - Peer Comparison
Screen NOVATEOR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Godrej Consumer Products | 126,391 | 69.83 | 14,680 | 2.19% | 1,852 | 77.82 |
| Dabur India | 92,693 | 49.81 | 13,113 | 1.76% | 1,740 | 49.44 |
| Colgate Palmolive | 56,848 | 42.95 | 6,179 | 7.33% | 1,437 | 42.69 |
| P&G Hygiene and Health Care | 41,725 | 50.98 | 3,412 | -19.87% | 637 | 52.79 |
| Gillette | 26,744 | 46.27 | 2,263 | -14.91% | 418 | 45.25 |
| Emami | 22,809 | 30.40 | 3,877 | 6.96% | 803 | 48.65 |
| Cupid | 11,274 | 228.22 | 203 | 13.97% | 41 | 93.38 |
| Mamaearth | 9,501 | 70.24 | 2,146 | 8.94% | 73 | 56.24 |
| Bajaj Consumer Care | 3,492 | 25.48 | 1,000 | -2.76% | 125 | 54.02 |
| Anondita Medicare | 1,831 | 113.76 | 77 | % | 16 | 91.10 |
Novateor Research Laboratories Company Announcements - News Screener
Screen NOVATEOR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Unaudited Financial Results For The Half Year Ended On 30.09.2025 | View |
| 2025-11-14 | Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended On September 30 2025 | View |
| 2025-11-08 | Board Meeting Intimation for Adoption Of Financial Results For The Half Year Ended On September 30 2025 | View |
| 2025-11-03 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-10-06 | Non Applicability Of Submission Of Related Party Disclosures For The Half Year Ended On September 30 2025 | View |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-08 | Reg. 34 (1) Annual Report. | View |
| 2025-09-08 | Notice Of 14Th AGM Of The Company | View |
| 2025-09-03 | The Cut Off Date To Determine The Eligible Shareholders Who Can Attend The 14Th AGM Of The Company | View |
| 2025-09-03 | 14Th Annual General Meeting Of The Company | View |
| 2025-09-03 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-09-03 | Reappointment Of Secretarial Auditor And Internal Auditor Of The Company | View |
| 2025-09-03 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Today September 03 2025 | View |
| 2025-08-31 | Board Meeting Intimation for Approval Of Agenda Related To Ensuing AGM And Other Businesses With The Permission Of Chairman | View |
| 2025-07-30 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |